Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vanda Reports Strong Phase III Data For Sleep Disorder Candidate In Chronic Insomnia

This article was originally published in The Pink Sheet Daily

Executive Summary

VEC-162 also being tested in transient insomnia, circadian rhythm sleep disorders and mood disorders.

You may also be interested in...



“Not Approvable” Letter Leaves Vanda’s Schizophrenia Drug With Cloudy Future

FDA requests additional Phase III comparative study and safety data for iloperidone.

“Not Approvable” Letter Leaves Vanda’s Schizophrenia Drug With Cloudy Future

FDA requests additional Phase III comparative study and safety data for iloperidone.

Actelion Accepts Payoff Risk In GSK Deal For Phase III Insomnia Drug

Almorexant deal guarantees Swiss biotech $148 million, but another $409 million rides on approval, and the $2.7 billion for new indications is a bio-bucks poster number.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

PS067992

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel